Schedule 13G ownership disclosure

FIVE PRIME THERAPEUTICS INC

Security class unavailable · CUSIP: 33830X104

Event date: 2015-01-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,519,882
Percent of class
6.0900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-15-000144
Form type
SC 13G
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Jan 15, 2015
Reporting period
Jan 07, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub